Literature DB >> 11330569

Glucose degradation products and peritoneal membrane function.

J Witowski1, T O Bender, G M Gahl, U Frei, A Jörres.   

Abstract

BACKGROUND: The bioincompatibility of peritoneal dialysis fluids (PDF) in current use has been partially attributed to the presence of glucose degradation products (GDPs), which are generated during heat sterilization of PDF. Several of the GDPs have been identified and we have recently demonstrated that these GDPs per se may impair the viability and function of human peritoneal mesothelial cells (HPMC) in vitro. It is also possible that GDP-related toxicity is further exacerbated by the milieu of PDF. We review the current literature on GDP and present the results of experiments comparing the impact of heat- and filter-sterilized PDF on the viability and function of HPMC.
METHODS: Peritoneal dialysis fluids with low (1.5%) and high (4.25%) glucose concentrations were laboratory prepared according to the standard formula and sterilized either by heat (H-PDF; 121 degrees C, 0.2 MPa, 20 minutes) or filtration (F-PDF; 0.2 microns). The buildup of GDP was confirmed by UV absorbance at 284 nm. Confluent HPMC monolayers were exposed to these solutions mixed 1:1 with standard M199 culture medium. After 24 hours, cell viability was assessed with the MTT assay, and interleukin-1beta-stimulated monocyte chemotactic protein-1 (MCP-1) release with specific immunoassay.
RESULTS: Exposure of HPMC to H-PDF resulted in a significant decrease in cell viability, with solutions containing 4.25% glucose being more toxic than 1.5% glucose-based PDF (27.4% +/- 3.4% and 53.4% +/- 11.0% of control values, respectively). In contrast, viability of HPMC exposed to F-PDF was not different from that of control cells. Moreover, treatment with H-PDF impaired the release of MCP-1 from HPMC to a significantly greater degree compared to F-PDF (17.4% and 24.9% difference for low and high glucose PDF, respectively).
CONCLUSIONS: Exposure of HPMC to H-PDF significantly impairs cell viability and the capacity for generating MCP-1 compared to F-PDF. This effect is likely to be mediated by GDPs present in H-PDF but not in F-PDF.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11330569

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  5 in total

1.  A new neutral-pH low-GDP peritoneal dialysis fluid.

Authors:  Rainer Himmele; Lynn Jensen; Dominik Fenn; Chih-Hu Ho; Dixie-Ann Sawin; Jose A Diaz-Buxo
Journal:  Perit Dial Int       Date:  2012-03-01       Impact factor: 1.756

2.  Effect of the peritoneal dialysis prescription on pentosidine in children.

Authors:  Aysun K Bayazit; Beth A Vogt; Katherine M Dell; Ira D Davis; Aytul Noyan; Ali Anarat; Ellis D Avner; Penny Erhard; Miriam F Weiss
Journal:  Pediatr Nephrol       Date:  2003-07-29       Impact factor: 3.714

3.  The Effect of Far-Infrared Therapy on the Peritoneal Expression of Glucose Degradation Products in Diabetic Patients on Peritoneal Dialysis.

Authors:  Chia-Ning Chang; Chih-Yuan Niu; Ann Charis Tan; Chia-Hao Chan; Chun-Fan Chen; Tz-Heng Chen; Szu-Yuan Li; Yung-Tai Chen; Fan-Yu Chen; Wen-Sheng Liu; Chih-Ching Lin; Guor-Jien Wei
Journal:  Int J Mol Sci       Date:  2021-04-02       Impact factor: 5.923

Review 4.  The potential role of NFAT5 and osmolarity in peritoneal injury.

Authors:  Harald Seeger; Daniel Kitterer; Joerg Latus; Mark Dominik Alscher; Niko Braun; Stephan Segerer
Journal:  Biomed Res Int       Date:  2015-09-30       Impact factor: 3.411

5.  Does Far-Infrared Therapy Improve Peritoneal Function and Reduce Recurrent Peritonitis in Peritoneal Dialysis Patients?

Authors:  Yuanmay Chang; Jui-Ting Chang; Mei-Yi Lee; Mei-Zen Huang; Yann-Fen C C Chao; Yung-Luen Shih; Yao-Rong Hwang
Journal:  J Clin Med       Date:  2022-03-15       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.